FineMark National Bank & Trust - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 3 filers reported holding KALA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,000
-33.3%
10,0000.0%0.00%
Q2 2022$3,000
-78.6%
10,0000.0%0.00%
-100.0%
Q1 2022$14,000
-46.2%
10,0000.0%0.00%0.0%
Q3 2021$26,000
-50.9%
10,0000.0%0.00%
-50.0%
Q2 2021$53,000
-20.9%
10,0000.0%0.00%
-33.3%
Q1 2021$67,000
-1.5%
10,0000.0%0.00%0.0%
Q4 2020$68,00010,0000.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 1,046,484$1,266,0001.02%
RA Capital Management 10,874,613$13,158,0000.23%
Samsara BioCapital, LLC 601,162$727,0000.14%
Matisse Capital 41,400$50,0000.04%
Manteio Capital LLC 19,546$24,0000.03%
Covestor Ltd 17,766$21,0000.03%
Knights of Columbus Asset Advisors LLC 241,857$293,0000.02%
Virtu Financial LLC 126,231$153,0000.02%
Aquatic Capital Management LLC 6,200$8,0000.02%
CAXTON CORP 13,155$16,0000.01%
View complete list of KALA PHARMACEUTICALS INC shareholders